Cargando…
Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss
The TGFβ signaling mediator SMAD4 is frequently mutated or deleted in colorectal and pancreatic cancers. SMAD4 acts as a tumor suppressor and its loss is associated with poorer patient outcomes. The purpose of this study was to find synthetic lethal interactions with SMAD4 deficiency to find novel t...
Autores principales: | Erasimus, Hélène, Kolnik, Vanessa, Lacroix, Frédéric, Sidhu, Sukhvinder, D'Agostino, Stéphane, Lemaitre, Olivier, Rohaut, Alexandre, Sanchez, Isabelle, Thill, Gilbert, Didier, Michel, Debussche, Laurent, Marcireau, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158796/ https://www.ncbi.nlm.nih.gov/pubmed/37377893 http://dx.doi.org/10.1158/2767-9764.CRC-22-0301 |
Ejemplares similares
-
CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
por: Castells-Roca, Laia, et al.
Publicado: (2021) -
Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition
por: Wang, Chao, et al.
Publicado: (2018) -
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2022) -
Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs
por: Tang, Shan, et al.
Publicado: (2022) -
Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen
por: Glinkina, Kseniya, et al.
Publicado: (2022)